Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. GeneDx Holdings Corp shares valued at $490,854 were sold by Feeley Kevin on Jul 09 ’25. At $93.00 per share, Feeley Kevin sold 5,278 shares. The insider’s holdings dropped to 3,392 shares worth approximately $0.28 million following the completion of this transaction.
Also, Stueland Katherine sold 3,220 shares, netting a total of over 299,460 in proceeds. Following the sale of shares at $93.00 each, the insider now holds 1,720 shares.
Before that, Stueland Katherine had sold 9,657 shares from its account. In a trade valued at $878,181, the Chief Executive Officer traded GeneDx Holdings Corp shares for $90.94 each. Upon closing the transaction, the insider’s holdings decreased to 9,657 shares, worth approximately $0.4 million.
As published in their initiating research note from Piper Sandler on July 09, 2025, GeneDx Holdings Corp [WGS] has been an Overweight and the price target has been revised to $110. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in mid May. As of May 09, 2025, Jefferies has increased its “Hold” rating to a “Buy” for WGS. Earlier on August 28, 2024, Wells Fargo initiated its rating. Their recommendation was “an Equal weight” for WGS stock.
Analyzing WGS Stock Performance
On last trading session,, GeneDx Holdings Corp [NASDAQ: WGS] plunged -1.81% to $81.45. The stock’s lowest price that day was $81.47, but it reached a high of $84.35 in the same session. During the last five days, there has been a surge of approximately 1.28%. Over the course of the year, GeneDx Holdings Corp shares have jumped approximately 150.46%. Shares of the company reached a 52-week high of $117.75 on 04/29/25 and a 52-week low of $55.17 on 05/08/25.
Support And Resistance Levels for GeneDx Holdings Corp (WGS)
According to the 24-hour chart, there is a support level at 80.48, which, if violated, would cause prices to drop to 79.52. In the upper region, resistance lies at 83.38. The next price resistance is at 85.32. RSI (Relative Strength Index) is 50.37 on the 14-day chart, showing neutral technical sentiment.
Is GeneDx Holdings Corp subject to short interest?
Stocks of GeneDx Holdings Corp saw a sharp rise in short interest on 2025-06-30 jumping by 38647.0 shares to 3.67 million. Data from Yahoo Finance shows that the short interest on 2025-05-30 was 3.64 million shares. A jump of 1.05% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.91 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.91.
Which companies own the most shares of GeneDx Holdings Corp (WGS)?
In terms of GeneDx Holdings Corp share price expectations, FactSet research, analysts set an average price target of 39.5 in the next 12 months, down nearly -52.38% from the previous closing price of $82.95. Analysts anticipate GeneDx Holdings Corp stock to reach 70 by 2025, with the lowest price target being 21. In spite of this, 3 analysts ranked GeneDx Holdings Corp stock as Buy at the end of 2025. On July 10, 2024, Craig Hallum assigned a price target of “a Buy” to the stock and initiated coverage with a $43.
